The failure to develop a magic-bullet drug that safely promotes weight loss is itself evidence. It says one thing. A reductionist answer, built on a single biologic mechanism, is unlikely to explain the obesity epidemic. This is a complex system failure. Complex systems do not fail for one reason.
The numbers that frame it
In the United States, 52.3% of adults have either type 2 diabetes or prediabetes. Fewer than 12.2% were metabolically healthy in 2009–2016. On the rules used after 2021, fewer than 7% are. Six feedings a day is a recipe for insulin resistance (when cells stop answering insulin). Put those three facts together. They describe an environment. They do not describe a pile of personal failures of willpower.
Duality of interest
Drug company influence is everywhere in academic policy and among thought leaders. Say a company paid someone, and that person then recommends the company’s product. That is no longer reliably treated as a conflict of interest. It is softened into a duality of interest. The polite word is doing real work.
The link is measurable. The more money doctors get, the more brand-name drugs they tend to prescribe. Now look at the advice to reverse type 2 diabetes, hyperinsulinemia (too much insulin in the blood) and obesity. That advice points toward less medical intervention and more patient self-care. Nobody is paid to promote that.
Prescription medication as a cause of death
Prescription medications are now the third most common cause of death worldwide, after heart disease and cancer. That statistic is alarming on its face. And the groups best placed to know do not dispute it. The Academy of Medical Royal Colleges and the BMJ have published a blueprint aimed at reducing it.
How long change takes
The first published evidence linked smoking to lung cancer. It then took nearly fifty years until real rules cut tobacco use. Big tobacco’s playbook in that time is well documented, and it has been reused. Max Planck’s point applies: science moves forward one funeral at a time.
Breaking news that is not new
A study published in Obesity reported that lifestyle interventions can produce sustained weight loss. These programs change diet and physical activity through behavioral strategies. The study is presented as news. It is not new. What stands out is which findings get pushed loud and which do not. That tracks funding more closely than newness.
The clinician’s own metabolic health
Overweight or obese doctors were less likely to talk about weight with heavy patients. Only 18% of them did so, against 30% of normal-weight doctors. That is not an argument for judging clinicians. It is an argument for seeing that the same environment acts on the people giving care. In this system, most clinicians are themselves metabolically unwell. A system like that will not fix itself with pep talks.
Related reading
Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP
Interventional pain physician, addiction medicine specialist and obesity medicine diplomate.
Licensed in Missouri and Illinois.
Last reviewed August 25, 2026
